1. Home
  2. REA vs RNAC Comparison

REA vs RNAC Comparison

Compare REA & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rare Earths Americas Inc. Common Stock

REA

Rare Earths Americas Inc. Common Stock

HOLD

Current Price

$7.37

Market Cap

205.9M

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$6.09

Market Cap

218.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REA
RNAC
Founded
2021
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.9M
218.4M
IPO Year
2026
2016

Fundamental Metrics

Financial Performance
Metric
REA
RNAC
Price
$7.37
$6.09
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$25.53
★ $33.67
AVG Volume (30 Days)
★ 130.6K
129.2K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $2,797,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$6.20
$5.60
52 Week High
$17.84
$11.00

Technical Indicators

Market Signals
Indicator
REA
RNAC
Relative Strength Index (RSI) 26.76 27.84
Support Level N/A $5.88
Resistance Level $10.58 $6.60
Average True Range (ATR) 0.68 0.36
MACD -0.22 -0.04
Stochastic Oscillator 25.25 6.73

Price Performance

Historical Comparison
REA
RNAC

About REA Rare Earths Americas Inc. Common Stock

Rare Earths Americas Inc is an exploration stage company focused on advancing projects related to rare earth minerals. Its activities include evaluating mineralization and assessing the characteristics and economic potential of its assets. Its portfolio includes the Shiloh Project in Georgia, United States; the Alpha Project in Bahia, Brazil; and the Constellation Project in Minas Gerais, Brazil. It also holds additional early-stage exploration projects, including the Homer Project in Goias, Brazil, and the Liberty Peak Project in Georgia, United States. The company has two reportable segments due to their geographical location: United States Mining Operations and Brazil Mining Operations.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: